Haemophilus influenzae type b conjugate vaccine (Chengdu Rongtian Bioengineering)

b型流感嗜血杆菌结合疫苗（成都蓉天生物工程）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHaemophilus influenzae type b conjugate vaccine (Chengdu Rongtian Bioengineering)

Drug Alias NameN/A

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Conjugated vaccineVaccines > Biological material > Bacterial vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsHaemophilus Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusDiscontinued (IND)

Highest Status in ChinaDiscontinued

Originator CompaniesChengdu Rongtian Bioengineering Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesChengdu Rongtian Bioengineering Co Ltd

Active IndicationsN/A

Inactive IndicationsHaemophilus Infections

Other Information

ATC CodeN/A